Health technology assessment 

Working with Visible Analytics for your HTA gives you access to first-class strategic, technical and communications support. 

We work with clients across Europe, North America and Asia Pacific, and have submitted to 18 different HTA agencies around the world. We often support local affiliates in multiple countries with model adaptation and training in model implementation.

Get in touch

Health technology assessment

Your partners in HTA

All of our Directors have over 20 years’ experience in HTA, and four are current or former members of NICE committees or have senior roles in evidence assessment groups. At least one Director is closely involved in every HTA project with additional high-level technical and strategic expertise available from within the company.

We can organize advisory boards, expert elicitations, mock committee meetings and HTA training.

We also offer early value assessment to help ensure that clinical trials and other evidence generation activities include the outcome measures required by payers for successful reimbursement.

HTA submissions

Our highly experienced team will support you through every aspect of the submission process. 

  • Our submissions tell a clear and consistent value story, with evidence presented clearly and concisely so that key points are rapidly understood.  We use our strategic and communications expertise to formulate clear and persuasive argumentation on complex and challenging issues.
  • We work as a team to ensure consistency between clinical and economic sections, with clinical aspects of the model (e.g. health states, adverse effects, care pathways, clinical assumptions) clearly introduced and supported. 
  • Strong project management is crucial; we set out and maintain timelines for all aspects of the submission package, communicating delivery and review timelines for all stakeholders and ensuring your submission comes together in good time.
  • You can count on our expert pre- and post-submission support, based on years of HTA experience in both consultancy and payer decision-making roles.

Case studies

Diagnostic device HTA assessment – from secondary to primary care

Diagnostic device HTA assessment – from secondary to primary care

To support an HTA assessment of a diagnostic device for use outside hospitals, we developed an economic assessment and submission dossier addressing GP collaboration, training, and pricing uncertainties. 

Optimisation of a payer value story to showcase the benefit of a treatment

Optimisation of a payer value story to showcase the benefit of a treatment

We optimised a cost-effectiveness model that initially lacked resonance and failed to demonstrate cost-effectiveness. 

Collaborative support for market access

Collaborative support for market access

We developed a comprehensive market access strategy to support HTA and reimbursement submissions for a product with a unique mode of action, whose benefits were only partially reflected in clinical trials.